We showed in a former study (Trojani et al., 1987) that immunohistochemical stainings on paraffin-embedded sections improved the detection of micrometastases in axillary lymph nodes and the prediction of recurrence and survival in invasive ductal carcinoma (IDC). The invasive lobular carcinoma (ILC) sample was considered too small to determine the prognostic value of micrometastases in this group. In this study, we have reviewed 91 cases of ILC in which axillary lymph nodes were free of metastases (average follow-up 6.5 years). The purpose was to determine first the increase in the detection rate of micrometastases by immunohistochemical procedure, and secondly the prognostic significance of these micrometastases.
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A series of 102 consecutive patients operated on for primary invasive lobular carcinoma (ILC) of the breast between 1965 and 1977 were selected for study (N-, MO). All slides of tumours and lymph nodes were reviewed to assess histologic tumour type and to ensure no occult metastasis had escaped our notice. Sixteen cases were excluded, 8 because micrometastases were detected at this second examination, and 8 because the carcinoma was not lobular in type. Thus, 86 cases were included in this study. They were treated by Patey mastectomy (73 cases) or by the combination of conservative surgery and radiation therapy (13 cases). All patients had an axillary node dissection. Eight of them had a contralateral lobular carcinoma: treatment was by axillary dissection in 5 of the cases which were invasive; the other 3, in situ, were not dissected. Thus 91 specimens of axillary node dissection were examined.
The mean number of lymph nodes in each case was 14 (range 2-29). The mean age of the patients was 58 years at operation (range 35-80 years). The average time of follow-up from surgery to the end of the study was 6.5 years and 45% of these patients fell into a 6-15 year period. Tumour size was distributed as follows: To: 3, T1:24, T2:48, T3: 4, TX: 7.
There was associated lobular carcinoma in situ in 63 cases (73%).
The number of recurrences was 8/86 (9%), 5 between 0 and 5 years, 3 between 5 and 10 years. There was no statistically significant difference in the recurrence rate between T1 or T2 patients (T1: 1/24, T2 2/48). The number of patients who died from their cancer was 4 (2 between 0 and 5 years; 1 at 7 years and 1 at 12 years), and 5 died of other causes.
As in our former study, the slides used were the original H & E sections (Voigt et al., 1986) , stained by a three stage immunoperoxidase procedure (Delsol et al., 1984) (Figures 1  and 2 ).
An increase in the immunohistochemical detection of micrometastases to axillary lymph nodes from breast carcinoma has been found in several studies including carcinomas of all histologic types. These metastases were more frequent in ILC than in IDC. Wells et al. (1984) studied 45 cases of invasive carcinoma (12 ILC and 33 IDC) and found 33% micrometastases in ILC compared to 9% in IDC. In our former study (Trojani et al., 1987) Months post mastectomy Figure 2 Micrometastases and survival of patients in the ILC group.
